News
The use of either prescription — which Dr. Ania Jastreboff tells PEOPLE are "nutrient-stimulated, hormone-based medications" that target the brain and affect satiety. As a result, the GLP-1 ...
Speaking to Dr. Ania Jastreboff the talk show host said for many years she thought that thin people had more willpower, saying: "They ate better foods. They were able to stick to it longer.
Hosted on MSN11mon
Ozempic Maker Plans to Study the Drug’s Effects on Alcohol ConsumptionAnia Jastreboff, M.D., PhD., an obesity medicine physician scientist at Yale University, spoke to PEOPLE last year about how some patients notice a reduced craving for alcohol while using Ozempic.
Hosted on MSN11mon
Kelly Osbourne Clarifies She's 'Never' Taken Ozempic but Says It's a 'Miracle Drug in the Right Hands' (Exclusive)Peptides are short chain amino acids, and according to Ania Jastreboff, M.D., PhD., who is an obesity medicine physician scientist at Yale University, the peptide semaglutide and other drugs in ...
5mon
Medpage Today on MSNZepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Yearsand 2.1% with placebo (P<0.001), reported Ania Jastreboff, MD, PhD, of the Yale Obesity Research Center at Yale University ...
Hosted on MSN11mon
Ozempic manufacturer Novo Nordisk launches study to find drug’s impact on reduced alcohol cravingsAnia Jastreboff, an obesity medicine physician scientist at Yale University, told People magazine last year that some patients noticed they had less desire to consume alcohol while taking Ozempic ...
In a recent episode of her podcast, she spoke with Dr. Ania Jastreboff and shared, "One of the things that I realized the very first time I took a [weight loss drug] was that all these years ...
The panel also included experts like Rachel Goldman, PhD (a psychologist we tapped for our State of Weight discussion), and Ania Jastreboff, MD, PhD, the director of the Yale Obesity Research Center.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results